Your session is about to expire
← Back to Search
Dexamethasone for Knee Surgery
Phase 4
Waitlist Available
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age > 18 years
Patients staying at least one night in the hospital after surgery
Must not have
Primary TKA requiring hardware removal
Current systemic fungal infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up <30 days after surgical intervention, document any readmissions to the hospital or complications that occur within 30 days from the day of surgery
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial
Summary
This trial is testing whether a lower dose of the steroid dexamethasone given during surgery can reduce postoperative pain and the need for opioids without increasing other complications.
Who is the study for?
This trial is for adults over 18 who are staying in the hospital at least one night after a primary total knee replacement surgery. It's not for those with inflammatory arthritis, current fungal infections, kidney or liver failure, planned same-day discharge, recent corticosteroid use, or a history of bad reactions to steroids.
What is being tested?
The study is testing three different doses of dexamethasone (16mg, 8mg/mL suspension, and 4mg) given during knee replacement surgery. The goal is to see which dose best reduces pain and opioid need after surgery while also lowering nausea/vomiting and complications.
What are the potential side effects?
Dexamethasone may cause side effects like increased blood sugar levels, higher risk of infection due to immune suppression, mood swings or sleep disturbances. Long-term use can lead to bone loss or stomach ulcers but this trial involves a single dose.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I stayed in the hospital overnight after my surgery.
Select...
I am having or have had a total knee replacement.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need to have hardware removed from my knee replacement.
Select...
I have a fungal infection in my body.
Select...
I am under 18 years old.
Select...
I will be discharged from the hospital on the same day of my procedure.
Select...
I have inflammatory arthritis.
Select...
I have kidney or liver failure.
Select...
I am having or have had a partial or complete knee replacement surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ <30 days after surgical intervention, document any readmissions to the hospital or complications that occur within 30 days from the day of surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~<30 days after surgical intervention, document any readmissions to the hospital or complications that occur within 30 days from the day of surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Opioid consumption
Secondary study objectives
Length of stay
Number of participants with complications (such as readmission to hospital) up to 30 days after surgical intervention
Postoperative Blood glucose levels and insulin use
+3 moreAwards & Highlights
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
3Treatment groups
Active Control
Group I: Group 1Active Control1 Intervention
4mg intravenous dexamethasone, administered shortly after induction of anesthesia
Group II: Group 2Active Control1 Intervention
8mg intravenous dexamethasone, administered shortly after induction of anesthesia
Group III: Group 3Active Control1 Intervention
16mg intravenous dexamethasone, administered shortly after induction of anesthesia
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
436 Previous Clinical Trials
248,848 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need to have hardware removed from my knee replacement.I have a fungal infection in my body.I am older than 18 years.I stayed in the hospital overnight after my surgery.I am under 18 years old.I will be discharged from the hospital on the same day of my procedure.I have not taken corticosteroids in the 3 months before surgery.I have inflammatory arthritis.I have kidney or liver failure.I am having or have had a partial or complete knee replacement surgery.I am having or have had a total knee replacement.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1
- Group 2: Group 2
- Group 3: Group 3
Awards:
This trial has 3 awards, including:- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.